Results 121 to 130 of about 4,056 (179)

Infographic: Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation in patients with proliferative diabetic retinopathy (PDR): the CLARITY study. [PDF]

Eye (Lond)
Yusuf IH, Henein C, Sivaprasad S.
europepmc   +1 more source

Infographic: Ranibizumab plus panretinal photocoagulation (PRP) versus PRP alone for high-risk proliferative diabetic retinopathy (PDR): the PROTEUS study. [PDF]

Eye (Lond)
Yusuf IH, Henein C, Sivaprasad S.
europepmc   +1 more source

Comment on the long-term effect of panretinal photocoagulation on optic nerve head parameters in diabetic retinopathy using Heidelberg retinal tomography III.

Oman J Ophthalmol
Panigrahi PK.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Panretinal Photocoagulation: A Review of Complications

Seminars in Ophthalmology, 2017
Panretinal photocoagulation (PRP) is a mainstay of therapy for retinal ischemic disease. The procedure involves creating thermal burns in the peripheral retina leading to tissue coagulation, the overall consequence of which is improved retinal oxygenation.
Shivani V, Reddy, Deeba, Husain
openaire   +2 more sources

PANRETINAL PHOTOCOAGULATION AND RETINAL OXYGENATION

Retina, 1982
Panretinal photocoagulation destroys some of the photoreceptors and thereby reduces the oxygen consumption in the outer retina and allows more O2 to flow from the choroid to the inner retina. Measurements of the preretinal oxygen tension were made in rhesus monkeys that had portions of their retinas photocoagulated.
M B, Landers, E, Stefansson, M L, Wolbarsht   +2 more
openaire   +2 more sources

Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy

Seminars in Ophthalmology, 2001
We misled to verify whether a panretinal photocoagulation (PRP) performed using low levels of ARGON laser energy (light PRP) has the same efficacy as a PRP performed in a conventional fashion using argon green wavelengths (classic PRP) in eyes with high-risk proliferative diabetic retinopathy (HRPDR).
Bandello F, BRANCATO, ROSARIO, MENCHINI, UGO, VIRGILI, GIANNI, Lanzetta P, Ferrari E, Incorvaia C.   +6 more
openaire   +5 more sources

Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

New England Journal of Medicine, 2011
A 55-year-old man with a 20-year history of type 2 diabetes mellitus was referred to a retina specialist after noticing a few black floaters in his left eye for the preceding week. His glycated hemoglobin level was 8.2%. He had no history of laser treatment for proliferative diabetic retinopathy in either eye.
Neil M, Bressler, Roy W, Beck, Frederick L, Ferris   +2 more
openaire   +2 more sources

Change in Diabetic Panretinal Photocoagulation Incidence

Ophthalmic Surgery, Lasers and Imaging Retina, 2012
BACKGROUND AND OBJECTIVE: Diabetic blindness occurs most often among working-age people. Panretinal photocoagulation (PRP) can prevent this outcome. Administrative data examined changes in PRP incidence rates. PATIENTS AND METHODS: Anonymous data from the “claims submitted” files of
Stephen S, Feman, Jiajing, Chen, Thomas E, Burroughs   +2 more
openaire   +2 more sources